Navigation Links
Ardea Biosciences Appoints John W. Beck Chief Financial Officer, Announces Clinical Development Progress and Reports First Quarter 2008 Financial Results
Date:5/9/2008

607 611

Other Income 135 184

Net loss $(12,375) $(3,369)

Non-cash dividends on Series A

Preferred stock (60) (60)

Net loss applicable to common

shareholders $(12,435) $(3,429)

Basic and diluted net loss per

share applicable to common

stockholders $(0.93) $(0.37)

Shares used to compute basic and

diluted net loss per share

applicable to common stockholders 13,337 9,373

Condensed Balance Sheet Data

(In Thousands)

March 31 December 31

2008 2007

Cash, cash equivalents and short-

term investments 56,164 66,215

Total assets 59,368 68,840

Total stockholders' equity 52,839 63,739

Statements contained in this press release regarding matters that are not historical facts are "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995. Because such statements are subject to risks and uncertainties, actual results may differ materially from those expressed or implied by such forward-looking statements. Such statements include, but are not limited to, statements regarding: sufficiency of cash resources and our goals, including the expected properties and benefits of RDEA806, RDEA427, RDEA119, RDEA436 and our other compounds and the results of preclinical, clinical and other studies. Risks that contribute to the uncer
'/>"/>

SOURCE Ardea Biosciences, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6

Related medicine technology :

1. Ardea Biosciences, Inc. Announces Completion of Phase 1 Clinical Trials of Novel Investigational HIV Drug RDEA806
2. Ardea Biosciences, Inc. Presents Results of Phase 1 Studies of RDEA806, a Novel NNRTI for HIV, at 47th ICAAC
3. Ardea Biosciences Lead MEK Inhibitor, RDEA119, to Enter Human Clinical Trials in Advanced Cancer Patients
4. Ardea Biosciences, Inc. Announces New Clinical Development Program Directed Toward the Treatment of Gout
5. Ardea Biosciences Presents Preclinical Data Demonstrating Favorable Resistance Profiles for Non-Nucleoside Reverse Transcriptase Inhibitors for the Treatment of Human Immunodeficiency Virus
6. Ardea Biosciences Reports Positive Phase 2a Results for Lead HIV Candidate, RDEA806, Demonstrating up to 2.0 Log Reduction in Plasma Viral Load
7. Ardea Biosciences Presents Data Demonstrating Favorable Pharmacokinetics and Efficacy for Mitogen-Activated ERK Kinase (MEK) Inhibitors
8. ImmuneRegen BioSciences Reports Material Transfer Agreement with VaxGen, Inc.
9. ImmuneRegen BioSciences, Inc. Demonstrates Radilex(TM) Increases Disease-Fighting White Blood Cells
10. Upstream Biosciences Acquires Innovative Platform Technology and Drug Candidates for Tropical Parasitic Diseases
11. Alacrity Biosciences Announces Positive Results from a Phase 2 Study of Its Dry Eye Treatment ALTY-0501
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/15/2014)... the leading health care supply chain expertise, analytics and ... national contracts that expand its portfolio to provide hospital ... These include manufacturer product and service agreements, as well ... IT consulting support. New Novation agreements ...
(Date:1/15/2014)... FORT WORTH, Texas , Jan. 15, 2014  Humberto ... in Dermatology Achievement Award" from the Journal of ... Dermatology Aesthetic & Clinical Conference (ODAC). The event is January ... Florida . The ...
(Date:1/15/2014)... , Jan. 15, 2014 Tegra Medical is very ... King as its new Chief Executive Officer.  Mark was ... which he has overseen the company,s four facilities in ... Costa Rica.  Mr. King joined Tegra Medical in 2012 with ...
Breaking Medicine Technology:New Novation Information Technology VAR Contracts Offer Significant Savings to Hospitals 2Galderma's global leader honored with a "Lifetime in Dermatology Achievement Award" by Journal of Drugs in Dermatology 2Galderma's global leader honored with a "Lifetime in Dermatology Achievement Award" by Journal of Drugs in Dermatology 3Galderma's global leader honored with a "Lifetime in Dermatology Achievement Award" by Journal of Drugs in Dermatology 4Tegra Medical Appoints New Chief Executive Officer 2Tegra Medical Appoints New Chief Executive Officer 3
... Medical Corporation has provided an educational grant to establish ... .  "Atrium has been proud to be the market ... McGill, Senior Vice President of Marketing and Corporate Communications. ... nurses and physicians, we decided to emphasize our commitment ...
... 15, 2011 Johnson & Johnson (NYSE: ... agreement with Merck regarding distribution rights for REMICADE® (infliximab) ... The amended agreement announced today in a separate news ... had been filed by Johnson & Johnson in May ...
Cached Medicine Technology:Atrium Provides Grant to Establish Education Web Site at AtriumU.com 2Johnson & Johnson Provides Additional Information Regarding Amended Agreement With Merck 2Johnson & Johnson Provides Additional Information Regarding Amended Agreement With Merck 3
(Date:7/10/2014)... News) -- Adults with dyslexia are more likely to ... teenagers than people who don,t have the learning disorder, ... affects up to 10 percent of people, causes problems ... of adults with this condition said they suffered physical ... those without dyslexia. "Even after accounting for age, ...
(Date:7/10/2014)... Dennis Thompson HealthDay ... Forget about the Twitter wars that break out regularly between ... be bad for your own relationship, a new study suggests. ... within a couple, even if the couple is in a ... 581 Twitter users. In turn, that friction can lead ...
(Date:7/10/2014)... who research issues ranging from child abuse to urban ... the International Society for Research on Aggression (ISRA) at ... University is hosting the prestigious world meeting, which is ... are excited to be bringing together leading scholars from ... fresh ideas about the causes, consequences and solutions to ...
(Date:7/10/2014)... known as the "Mississippi baby" an infant seemingly cured ... a prolonged remission of HIV infection in The New ... of HIV after more than two years of not taking ... HIV specialist and researchers involved in the case. ... this young child, the medical staff involved in the child,s ...
(Date:7/10/2014)... medical imaging far outweigh the risks when children receive ... Right Radiation Dose. However, overuse and misuse of imaging ... a collaborative effort to ensure a national protocol is ... Journal of Patient Safety , calls for the ... Accreditation Commission, and the Centers for Medicare & Medicaid ...
Breaking Medicine News(10 mins):Health News:Researchers See Link Between Dyslexia, Abuse 2Health News:Are You Tweeting Your Marriage Away? 2Health News:Are You Tweeting Your Marriage Away? 3Health News:Georgia State hosts national conference on aggression 2Health News:Georgia State hosts national conference on aggression 3Health News:'Mississippi Baby' now has detectable HIV, researchers find 2Health News:'Mississippi Baby' now has detectable HIV, researchers find 3Health News:Mayo Clinic calls for standardization of safe imaging protocols for children 2
... records and embedded tools can alert and direct pediatricians ... and teenagers, according to a new Kaiser Permanente study ... Researchers analyzed visits for nearly 740,000 children and ... of computer-assisted decision tools and found that extracting information ...
... News) -- Researchers who traced the evolution of a ... livestock to humans say their findings highlight the dangers ... The international team of scientists studied methicillin-resistant Staphylococcus ... livestock-associated MRSA, which most often infects people with direct ...
... you use your right hand to hold your cell phone up to ... in Detroit. The study finds a strong correlation between brain dominance ... than 70 percent of participants holding their cell phone up to the ... brain dominate people those whose speech and language center is on ...
... 2012 A simple blood test is being developed by ... University Medical Center in Beer-Sheva, Israel that may provide early ... BGU,s Faculty of Health Sciences and his team developed a ... of blood. The test uses infrared light to detect miniscule ...
... have discovered that cancer-causing genetic mutations have better-disguised electronic signatures ... them fly under the radar of the body,s defence mechanisms. ... University of Warwick and in Taiwan hint at the possibility ... a role in early diagnosis and detection of mutation hotspots. ...
... within each cell that regulate metabolism and energy use, ... according to a new study. Manipulation of two biochemical ... could shrink human lung cancers transplanted into mice, a ... FASEB . Within each cell, mitochondria are constantly ...
Cached Medicine News:Health News:Computer-assisted tools alert pediatricians to obese patients 2Health News:Computer-assisted tools alert pediatricians to obese patients 3Health News:Pig-to-Human 'Superbug' May Be Due to Animal Antibiotics 2Health News:Study: Brain makes call on which ear is used for cell phone 2Health News:Study: Brain makes call on which ear is used for cell phone 3Health News:'Stealth' properties of cancer-causing genetic mutations identified 2Health News:Energy network within cells may be new target for cancer therapy 2Health News:Energy network within cells may be new target for cancer therapy 3
... is a potent naturally occurring androgen ... of cholestenone 5a-reductase [1]. The ... certain peripheral tissues, including genital skin ... intra-cellularly in apparent association with the ...
The Bard Ellik Bladder Evacuator is designed for ease of maneuverability during the removal of tissue sections during transurethral prostatectomy, TURPs, bladder biopsy, etc....
UROSKOP Access, the dedicated urodiagnostic table with truly unrestricted patient access optimizes nearly all diagnostic and interventional procedures....
Drew Scientific has been making leading edge and top quality CBC systems for over 15 years.,The Excell 16/18 offers a reliable alternative for a 3 part differential....
Medicine Products: